CMC Biologics Announce Appointment of David Wolton as VP Manufacturing
CMC Biologics A/S announced the appointment of David Wolton, VP Manufacturing. During his 23 year biotech career, David has held positions with Elan, Wyeth and Lonza.
“We are delighted to add David’s tremendous experience to CMC Biologics. He has a proven track record in managing successful manufacturing teams and will bring new opportunities for production efficiencies”, said Peter Vilby, Chief Operating Officer.
“CMC Biologics continues to attract the highest calibre people in our industry, and David Wolton’s appointment will ensure continued delivery of products to our customers, in the highly demanding regulatory environment of biologicals”, said Mads Laustsen, CEO of CMC Biologics.
Most read news
Organizations
Other news from the department people
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.